Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Use of semaphorin-4D binding molecules for treating neurodegenerative disorders

Use of semaphorin-4D binding molecules for treating neurodegenerative disorders

US Patent 9598495 · Granted Mar 21, 2017

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Anti-CCR8 antibodies and uses thereof2025
Systems, apparatuses, and methods for filtering high voltage noise induced by pu2025
Systems, devices, and methods for signal generation2024
Use of semaphorin-4D antibodies in combination with an immune modulating therapy2024
Use of semaphorin-4D antibodies in combination with an immune modulating therapy2024
Anti-CD100 antibodies and methods for using the same2024
Human anti-semaphorin 4D antibody2024
Human anti-semaphorin 4D antibody2024
Anti-CXCL13 antibodies and methods of using the same2024
Integral membrane protein display on poxvirus extracellular enveloped virions2024
Anti-CCR8 antibodies and uses thereof2024
Use of semaphorin-4D binding molecules for the treatment of Rett syndrome2023